Investigation of Usability and Efficacy of Loratadine Rapidly Disintegrating Tablets (Claritin Reditabs)

DOI Web Site 3 Citations 9 References
  • FURUE Masutaka
    Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
  • IMAFUKU Shinichi
    Division of Dermatology, Kitakyushu Municipal Medical Center

Bibliographic Information

Other Title
  • ロラタジン口腔内速溶錠（クラリチンレディタブ錠）の使用感ならびに有用性の検討
  • 治療 ロラタジン口腔内速溶錠(クラリチンレディタブ錠)の使用感ならびに有用性の検討
  • チリョウ ロラタジン コウクウ ナイソクヨウジョウ クラリチンレディタブジョウ ノ シヨウカン ナラビニ ユウヨウセイ ノ ケントウ

Search this article

Description

A questionnaire survey on the usability and efficacy of loratadine rapidly disintegrating tablets (Claritin® Reditabs®) was conducted in 64 patients with pruritic skin disease (17 with urticaria, 25 with atopic dermatitis, and 22 with other eczema/dermatitis). Regarding overall ease of ingestion, 54 patients (84.4%) considered it “good”, 9 (14.1%) “neither good nor bad”, and 0 (0%) “bad”. Eleven patients (17.2%) sometimes “forgot to take” the drug and 53 (82.8%) did not forget to take the drug, with a significantly lower number of patinets “forgetting to take” the drug. Fifty-four patients (84.4%) stated that they wanted to continue the drug. The reasons for wanting to continue it (with multiple answers allowed) included “it is convenient to take the drug anywhere” for 28 patients (43.8%), “no need for water” for 25 (39.1%), and “once-daily ingestion” for 23 (35.9%). It was found that the rapidly disintegrating tablet dosage form improved drug compliance.

Journal

Citations (3)*help

See more

References(9)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top